3-D Matrix,Ltd. (7777)

Market cap
¥54.7B
P/E ratio
59.2x
Three-D Matrix develops and sells medical devices and pharmaceuticals using exclusive MIT-licensed self-assembling peptide technology for surgery, tissue regeneration, and drug delivery.
Period EndIncome before tax (Million JPY)YoY (%)
Apr 30, 2025-2,484-1872.34%
Apr 30, 2024140-105.95%
Apr 30, 2023-2,357+30.41%
Apr 30, 2022-1,807-4.91%
Apr 30, 2021-1,900-35.69%
Apr 30, 2020-2,955+21.79%
Apr 30, 2019-2,426+37.30%
Apr 30, 2018-1,767+39.12%
Apr 30, 2017-1,270-34.39%
Apr 30, 2016-1,936+7.83%
Apr 30, 2015-1,795+17.81%
Apr 30, 2014-1,524+55.89%
Apr 30, 2013-978-415.77%
Apr 30, 2012310
AI Chat